✦ LIBER ✦

Designing neuroprotection trials in Parkinson's disease

✍ Scribed by Karl Kieburtz

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 100 KB
Volume: 53
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.10484

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neuroprotection in Parkinson's disease:

Neuroprotection in Parkinson's disease: Clinical trials

✍ Fabrizio Stocchi; C. Warren Olanow 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 2 views

Bioenergetic approaches for neuroprotect

Bioenergetic approaches for neuroprotection in Parkinson's disease

✍ M. Flint Beal 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

Neuroprotective clinical strategies for

Neuroprotective clinical strategies for Parkinson's disease

✍ Dr. Ira Shoulson 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB 👁 2 views

Neuroprotection for Parkinson's disease:

Neuroprotection for Parkinson's disease: Prospects and promises

✍ C. Warren Olanow; Anthony H. V. Schapira; Yves Agid 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB 👁 2 views

Imaging end points for monitoring neurop

Imaging end points for monitoring neuroprotection in Parkinson's disease

✍ David J. Brooks 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB 👁 2 views

In this review, the potential role of positron emission tomography and single-photon emission computed tomography as biological markers for following the progression of Parkinson's disease (PD) is discussed, and their value for assessing the efficacy of putative neuroprotective agents in PD is consi

Why have we failed to achieve neuroprote

Why have we failed to achieve neuroprotection in Parkinson's disease?

✍ C. Warren Olanow; Karl Kieburtz; Anthony H. V. Schapira 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 1 views